ASCO23: ‘Safety & efficacy of the novel BRAF inhibitor FORE8394 in patients with advanced solid & CNS tumors’
MIAMI, FLORIDA (EMBARGOED UNTIL MAY 25, 2023, AT 5 P.M. ET) – An early-phase study led by researchers at Sylvester ...
-
Nearly 70% of private label avocado oil rancid or mixed with other oils
-
Null results research now published by major behavioral medicine journal
-
UC Davis C-STEM trains Redlands teachers on bringing computer science into math
-
Mozart may reduce seizure frequency in people with epilepsy
-
The promise of novel FolRα-targeting antibody drug conjugate in recurrent epithelial ovarian cancer
-
Phase 3 SWOG Cancer Research Network trial, led by a City of Hope researcher, demonstrates one-year progression-free survival in 94% of patients with Stage 3 or 4 classic Hodgkin lymphoma who received a checkpoint inhibitor combined with chemotherapy
ADVERTISEMENT
About us
We bring you the latest science news from best research centers and universities around the world. Check our website.
Subscribe to Blog via Email
Join 206 other subscribers
© 2023 Scienmag- Science Magazine: Latest Science News.